- Home
- Publications
- Publication Search
- Publication Details
Title
NRF2 in Cardiovascular Diseases: a Ray of Hope!
Authors
Keywords
-
Journal
Journal of Cardiovascular Translational Research
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-26
DOI
10.1007/s12265-020-10083-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardamonin protects against lipopolysaccharide-induced myocardial contractile dysfunction in mice through Nrf2-regulated mechanism
- (2020) Ying Tan et al. ACTA PHARMACOLOGICA SINICA
- Exosomal Nrf2: From anti-oxidant and anti-inflammation response to wound healing and tissue regeneration in aged-related diseases
- (2020) Houman Kahroba et al. BIOCHIMIE
- Beyond repression of Nrf2: An update on Keap1
- (2020) Aleksandra Kopacz et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
- (2019) Kah Yong Goh et al. Redox Biology
- The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats
- (2019) Long Zhang et al. DRUG DEVELOPMENT RESEARCH
- Protective effects of two novel nitronyl nitroxide radicals on heart failure induced by hypobaric hypoxia
- (2019) Linlin Jing et al. LIFE SCIENCES
- Thyroid hormone protects cardiomyocytes from H2O2-induced oxidative stress via the PI3K-AKT signaling pathway
- (2019) Bin Zeng et al. EXPERIMENTAL CELL RESEARCH
- Kaempferol prevents against Ang II- induced cardiac remodeling via attenuating Ang II-induced inflammation and oxidative stress
- (2019) Yao Du et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Zingerone attenuates aortic banding‐induced cardiac remodelling via activating the eNOS/Nrf2 pathway
- (2019) Chen Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
- (2019) Natalia Robledinos-Antón et al. Oxidative Medicine and Cellular Longevity
- Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
- (2019) Pei Nie et al. Oxidative Medicine and Cellular Longevity
- Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure
- (2019) Anyun Ma et al. FREE RADICAL BIOLOGY AND MEDICINE
- Exercise Training Upregulates Nrf2 Protein in the Rostral Ventrolateral Medulla of Mice with Heart Failure
- (2019) Ahmed M. Wafi et al. JOURNAL OF APPLIED PHYSIOLOGY
- Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
- (2019) Changhai Tian et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Galanthamine improves myocardial ischemia-reperfusion-induced cardiac dysfunction, endoplasmic reticulum stress-related apoptosis, and myocardial fibrosis by suppressing AMPK/Nrf2 pathway in rats
- (2019) Xiaolin Hou et al. Annals of Translational Medicine
- Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
- (2018) Melanie P. Chin et al. AMERICAN JOURNAL OF NEPHROLOGY
- Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure
- (2018) Changhai Tian et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
- (2018) Lu Gao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors
- (2018) Samir Rabadiya et al. BIOMEDICINE & PHARMACOTHERAPY
- Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy
- (2018) Basant Sharma et al. Cardiovascular Toxicology
- Opioids in Cardiovascular Disease: Therapeutic Options
- (2018) Hemangi Rawal et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Fasudil alleviates pressure overload-induced heart failure by activating Nrf2-mediated antioxidant responses
- (2018) Peng Guan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Nrf2 at the heart of oxidative stress and cardiac protection
- (2018) Qin M. Chen et al. PHYSIOLOGICAL GENOMICS
- Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cells
- (2018) Takeaki Shinjo et al. PLoS One
- Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats
- (2018) Shao-Ai Cai et al. Frontiers in Pharmacology
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator
- (2018) Paul W. Armstrong et al. JACC-Heart Failure
- Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway
- (2018) Ying Xin et al. Redox Biology
- Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction
- (2018) Yuan Liu et al. Redox Biology
- Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress
- (2018) Andrey Kazakov et al. BASIC RESEARCH IN CARDIOLOGY
- Stilbenoid pterostilbene complexed with cyclodextrin preserves left ventricular function after myocardial infarction in rats: possible involvement of thiol proteins and modulation of phosphorylated GSK-3β
- (2018) Denise Lacerda et al. FREE RADICAL RESEARCH
- Relaxin protects cardiomyocytes against hypoxia-induced damage in in-vitro conditions: Involvement of Nrf2/HO-1 signaling pathway
- (2018) Ajaz Ahmad Waza et al. LIFE SCIENCES
- Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials
- (2018) Ravi B. Patel et al. Annual Review of Pharmacology and Toxicology
- Curcumin Improves Exercise Performance of Mice with Coronary Artery Ligation Induced HFrEF: Nrf2 and Antioxidant Mechanisms in Skeletal Muscle
- (2018) Ahmed M. Wafi et al. JOURNAL OF APPLIED PHYSIOLOGY
- Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses
- (2018) Li Li et al. PHYTOMEDICINE
- Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling
- (2018) Bin Zhang et al. Frontiers in Pharmacology
- The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches
- (2018) Bee Kee Ooi et al. Frontiers in Pharmacology
- Update on heart failure management and future directions
- (2018) Hong-Mi Choi et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling
- (2017) Kristen J. Bubb et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Role of Nrf2 in Cardiovascular Function and Disease
- (2017) Sandro Satta et al. Oxidative Medicine and Cellular Longevity
- Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction
- (2017) Joshua Strom et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Soybean isoflavones ameliorate ischemic cardiomyopathy by activating Nrf2-mediated antioxidant responses
- (2017) Yang Li et al. Food & Function
- Protective effect of hydrogen sulphide against myocardial hypertrophy in mice
- (2017) Mingjing Shao et al. Oncotarget
- Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis
- (2017) William L. Baker et al. Journal of the American Heart Association
- CVD and Oxidative Stress
- (2017) Karla Cervantes Gracia et al. Journal of Clinical Medicine
- Cardiac Cachexia: Perspectives for Prevention and Treatment
- (2016) Marina Politi Okoshi et al. Arquivos Brasileiros de Cardiologia
- Obestatin attenuated doxorubicin-induced cardiomyopathy via enhancing long noncoding Mhrt RNA expression
- (2016) Hong-qi Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent MannerCLINICAL PERSPECTIVE
- (2016) Yuuki Shimizu et al. Circulation-Heart Failure
- Protein levels in Keap1-Nrf2 system in human failing heart
- (2016) Masaaki Konishi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor‐Erythroid 2‐Related Factor 2 (Nrf2)‐Dependent Signaling in Chronic Heart Failure
- (2016) Erminia Donnarumma et al. Journal of the American Heart Association
- Mechanisms of Cachexia in Chronic Disease States
- (2015) Tadashi Yoshida et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention
- (2015) Bryan Harder et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Myocardial Infarction: Symptoms and Treatments
- (2015) Lei Lu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Heart Disease and Stroke Statistics—2016 Update
- (2015) Dariush Mozaffarian et al. CIRCULATION
- Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function
- (2015) Ralf Erkens et al. FREE RADICAL BIOLOGY AND MEDICINE
- Structural basis of Keap1 interactions with Nrf2
- (2015) Peter Canning et al. FREE RADICAL BIOLOGY AND MEDICINE
- Downregulation of Nuclear Factor Erythroid 2–Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in Hypertension
- (2015) Rhéure A. Lopes et al. HYPERTENSION
- Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy InsufficiencyNovelty and Significance
- (2015) Qingyun Qin et al. HYPERTENSION
- Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2
- (2015) Hui Wang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats
- (2015) Yuanyuan Qian et al. PLoS One
- Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus
- (2014) Bhoomika M. Patel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation
- (2014) Antonio Cuadrado et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats
- (2014) Bhoomika R. Goyal et al. Pharmacological Reports
- Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications
- (2014) Suchi Raghunathan et al. Biomed Research International
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril
- (2013) Bhoomika M. Patel et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Choice of anti-hypertensive agents in diabetic subjects
- (2013) Bhoomika M Patel et al. Diabetes & Vascular Disease Research
- Effect of Spironolactone on Cardiovascular Complications Associated with Type-2 Diabetes in Rats
- (2013) B. Patel et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Notch-Nrf2 Axis: Regulation of Nrf2 Gene Expression and Cytoprotection by Notch Signaling
- (2013) N. Wakabayashi et al. MOLECULAR AND CELLULAR BIOLOGY
- Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration
- (2013) K. M. Holmstrom et al. Biology Open
- Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells
- (2013) Megan L. Steele et al. Redox Biology
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases
- (2012) Bhoomika M. Patel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Therapeutic implications of small interfering RNA in cardiovascular diseases
- (2012) Suchi Raghunathan et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations
- (2012) BM Patel et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Systemic Heme Oxygenase-1 Transgenic Overexpression Aggravates Pressure Overload-induced Cardiac Hypertrophy in Mice
- (2011) Chang Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
- (2011) Y. Tan et al. DIABETES
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection
- (2010) Berenice Barajas et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
- (2010) Deepti Malhotra et al. NUCLEIC ACIDS RESEARCH
- Investigation Into the Cardiac Effects of Spironolactone in the Experimental Model of Type 1 Diabetes
- (2009) Bhoomika R Goyal et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Does Increased Oxidative Stress Cause Hypertension?
- (2008) E. Grossman DIABETES CARE
- Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats
- (2008) Bhoomika R. Goyal et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Disruption of Nrf2, a Key Inducer of Antioxidant Defenses, Attenuates ApoE-Mediated Atherosclerosis in Mice
- (2008) Thomas E. Sussan et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started